| Primary |
| Product Used For Unknown Indication |
20.6% |
| Type 2 Diabetes Mellitus |
17.6% |
| Drug Use For Unknown Indication |
14.7% |
| Diabetes Mellitus |
8.8% |
| Diabetes Mellitus Non-insulin-dependent |
7.6% |
| Hypertension |
6.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
5.9% |
| Ill-defined Disorder |
4.7% |
| Blood Cholesterol Increased |
2.4% |
| Glaucoma |
2.4% |
| Cardiac Failure |
1.2% |
| Colon Cancer |
1.2% |
| Hepatitis C |
1.2% |
| Labour Induction |
1.2% |
| Prostatomegaly |
1.2% |
| Anxiety |
0.6% |
| Arrhythmia |
0.6% |
| Breast Cancer |
0.6% |
| Constipation |
0.6% |
| Depression |
0.6% |
|
| Weight Decreased |
10.5% |
| Anaphylactic Shock |
7.9% |
| Hepatitis Cholestatic |
7.9% |
| Sepsis |
7.9% |
| Transient Ischaemic Attack |
7.9% |
| Blood Glucose Increased |
5.3% |
| Hepatic Failure |
5.3% |
| Hepatotoxicity |
5.3% |
| Hypoglycaemic Unconsciousness |
5.3% |
| Intraocular Pressure Increased |
5.3% |
| Medication Error |
5.3% |
| Sudden Cardiac Death |
5.3% |
| Anaemia |
2.6% |
| Angioneurotic Oedema |
2.6% |
| Autoimmune Hepatitis |
2.6% |
| Back Pain |
2.6% |
| Brain Injury |
2.6% |
| Breast Cancer |
2.6% |
| Convulsion |
2.6% |
| Disturbance In Attention |
2.6% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
27.9% |
| Diabetes Mellitus |
24.7% |
| Drug Use For Unknown Indication |
10.0% |
| Immunosuppression |
9.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
5.3% |
| Diabetes Mellitus Non-insulin-dependent |
3.2% |
| Hypertension |
3.2% |
| Prophylaxis |
2.1% |
| Prostatomegaly |
2.1% |
| Nasopharyngitis |
1.6% |
| Arrhythmia |
1.1% |
| Back Pain |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Breast Cancer |
1.1% |
| Depression |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Ill-defined Disorder |
1.1% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.1% |
| Oedema Peripheral |
1.1% |
|
| Hepatic Failure |
13.0% |
| Weight Decreased |
11.1% |
| Blood Glucose Increased |
7.4% |
| Drug Ineffective |
7.4% |
| Loss Of Consciousness |
7.4% |
| Gallbladder Disorder |
5.6% |
| Myocardial Infarction |
5.6% |
| Vomiting |
5.6% |
| Abdominal Infection |
3.7% |
| Herpes Zoster |
3.7% |
| Hypoglycaemic Unconsciousness |
3.7% |
| Leukoencephalopathy |
3.7% |
| Pancreatitis |
3.7% |
| Pyelonephritis Acute |
3.7% |
| Somnolence |
3.7% |
| Weight Increased |
3.7% |
| Blood Glucose Decreased |
1.9% |
| Diabetic Ketoacidosis |
1.9% |
| Drug Hypersensitivity |
1.9% |
| Glycosylated Haemoglobin Increased |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.9% |
| Diabetes Mellitus |
14.1% |
| Product Used For Unknown Indication |
13.5% |
| Diabetes Mellitus Non-insulin-dependent |
12.9% |
| Type 2 Diabetes Mellitus |
11.2% |
| Hypertension |
7.9% |
| Depression |
2.9% |
| Blood Cholesterol Increased |
2.3% |
| Pain |
2.2% |
| Atrial Fibrillation |
2.1% |
| Nuclear Magnetic Resonance Imaging |
1.9% |
| Multiple Myeloma |
1.7% |
| Osteoporosis |
1.5% |
| Cardiac Disorder |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Hypothyroidism |
1.1% |
| Prophylaxis |
1.1% |
| Breast Cancer |
1.1% |
| Anxiety |
1.1% |
| Anaemia |
1.0% |
|
| Weight Decreased |
30.4% |
| Blood Glucose Increased |
8.9% |
| Weight Increased |
8.2% |
| Nausea |
7.1% |
| Vomiting |
6.6% |
| Myocardial Infarction |
5.7% |
| Pneumonia |
4.8% |
| Drug Ineffective |
2.7% |
| Cardiac Failure Congestive |
2.6% |
| Tremor |
2.6% |
| Injection Site Pain |
2.4% |
| Transient Ischaemic Attack |
2.4% |
| Pain |
2.1% |
| Pancreatitis |
2.1% |
| Death |
2.0% |
| Oedema Peripheral |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Cerebrovascular Accident |
1.8% |
| Pruritus |
1.8% |
| Type 1 Diabetes Mellitus |
1.8% |
|
